BioLife Solutions, Inc. (BLFS) Operating cash flow 2016–2025
BioLife Solutions, Inc. (BLFS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$20.1MFY2025 · since FY2016: -$4.3M → $20.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $20.1M | +138.6% |
| FY2024 | $8.4M | +167.5% |
| FY2023 | -$12.5M | -47.2% |
| FY2022 | -$8.5M | -84.8% |
| FY2021 | -$4.6M | -169.1% |
| FY2020 | $6.6M | +447.8% |
| FY2019 | $1.2M | -48.3% |
| FY2018 | $2.3M | +288.1% |
| FY2017 | $605,000 | +114.0% |
| FY2016 | -$4.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BLFS financial trends
BLFS RevenueBLFS Net incomeBLFS Net marginBLFS Gross profitBLFS Gross marginBLFS Operating incomeBLFS Operating marginBLFS Free cash flowBLFS Capital expendituresBLFS Return on equityBLFS Stock buybacksBLFS Dividends paidBLFS Total assetsBLFS Total liabilitiesBLFS Shareholders’ equityBLFS overview →